Herbal Remedies in Diabetes: A Comparative Review of Fenugreek, Bitter Gourd, and Cinnamon
Abstract
Diabetes mellitus is a major global metabolic disorder characterized by chronic hyperglycemia resulting from impaired insulin secretion, insulin resistance, or both. Despite the wide availability of conventional antidiabetic therapies, long-term treatment challenges—including adverse effects, high cost, reduced patient adherence, and the inability to target multiple metabolic pathways simultaneously—have intensified interest in plant-based complementary remedies. This review provides a comprehensive comparative evaluation of three widely used antidiabetic herbs: fenugreek (Trigonella foenum-graecum), bitter gourd (Momordica charantia), and cinnamon (Cinnamomum spp.). The phytochemical profiles, mechanisms of action, pharmacological activities, clinical evidence, safety considerations, and therapeutic potential of each herb are critically analyzed. Fenugreek exhibits glycemic benefits primarily through 4-hydroxyisoleucine–stimulated insulin secretion, galactomannan-mediated delayed carbohydrate absorption, and enhanced insulin sensitivity. Bitter gourd demonstrates insulin-mimetic activity via polypeptide-P, AMPK activation by charantin, and improved glucose uptake through GLUT-4 translocation. Cinnamon contributes to glycemic regulation by enhancing insulin receptor signaling, inhibiting carbohydrate-hydrolyzing enzymes, reducing oxidative stress, and improving β-cell function, with cinnamaldehyde and procyanidins as key contributors. While strong preclinical evidence supports the antidiabetic efficacy of all three herbs, human clinical outcomes remain variable due to differences in species, extract standardization, and study design. Overall, fenugreek, bitter gourd, and cinnamon show promise as adjunct therapies in diabetes management, offering multi-target metabolic benefits. However, standardized formulations and large-scale clinical trials are essential to validate their therapeutic potential, optimize dosage, and ensure safety in long-term use.
Fields of Study & Subjects
Natural Antidiabetic Agents Studies
Medicinal Plant Research
Pancreatic function and diabetes
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 16 January 2026